76

THE 63RD ANNUAL MEETING OF THE JAPANESE SOCIETY FOR VIROLOGY

Chair Yasuko Mori Kobe University

Betaherpesvirinae

P2-G-001 唾液中のヒトヘルペスウイルス７量による自然免疫力レベルの新規判定方法およびパン酵母ベータグルカン摂取による自然免疫力レベル向上改善効果Tsunesuke Kajimoto1），Akiyoshi Hanawa2），Shinya Kurata2）

1）Healthcare Network Department, Finggal Link Co., Ltd.，2）J-Bio21 Centre, Nippon Steel & Sumikin Eco-Tech Corporation

P2-G-002 突発性発疹患児急性期から回復期における唾液中の HHV-6B，HHV-7経時的モニタリングYuki Miyazaki1），Hikaru Nanba1），Sadayushi Torigoe2），Masahiro Watanabe3），Nobuko Yamashita1），Hiroto Ogawa1），Tsuneo Morishima3），Masao Yamada1）

1）Department of Virology, Graduate School of Medicine, Dentistry, Pharmaceutical Sciences, Okayama University，2）Aquair Medical Station，3）Suzuka Pediatrics，4）Okayama Rosai Hospital

P2-G-003 マウスサイトメガロウイルス胎盤内感染モデルを用いた大脳皮質形成障害発生機構の解析Isao Kosugi1），Makiko Sakao2），Hideya Kawasaki1），Toshihide Iwashita1）

1）Department of Regenerative & Infectious Pathology, Hamamatsu University School of Medicine，2）Department of Neurology, Hamamatsu University School of Medicine

P2-G-004 サイトメガロウイルスの経母乳感染予防を目的とした電子レンジによる加温法の検討Kosuke Takeshima，Yoko Yanagawa，Kazuo TanakaDepartment of Microbiology and Immunology Showa University School of Medicine

P2-G-005 CCL2-CCR2 dependent-human cytomegalovirus replication

CCL2-CCR2に依存したヒトサイトメガロウイルスの複製Tsugiya Murayama，Takaki Miita，Rie Yamada，Hidetaka Sadanari，Keiko MatsubaraDepartment of Microbiology and Immunology, Faculty of Pharmaceutical Sciences, Hokuriku University

P2-G-006 サイトメガロウイルス（CMV）特異的な細胞性免疫測定法の確立Junichi Sato，Kazufumi Ikuta，Takahiro Kobayashi，Tatsuo SuzutaniDepartment of Microbiology, the Fukushima Medical University, School of Medicine

P2-G-007 STAT のリン酸化に対する抗ヒトサイトメガロウイルス活性のある tricin の影響についてHidetaka Sadanari，Masaya Takemoto，Rie Yamada，Tsugiya MurayamaDepartment of Pharmaceutical Sciences, Hokuriku University

P2-G-008 Functional analysis of the cytoplasmic tail of CD134 during HHV-6B infection

HHV-6B 侵入における CD134分子の細胞質側領域の機能解析Miwako Nagasaka1,2），Shinsaku Nakazawa1），Michio Mugitani1），Akiko Kawabata1），Tang Huamin1），Ichiro Morioka2），Kazumoto Iijima2），Yasuko Mori1）

1）Division of Clinical Virology, Kobe University Graduate School of Medicine，2）Department of Pediatrics, Kobe University Graduate School of Medicine

P2-G-009 Investigation of mechanism for human herpesvirus (HHV-) 6 and HHV-7 reactivation in sleep apnea syndrome.

睡眠時無呼吸症候群を対象とした，HHV-6，HHV-7の再活性化メカニズムの検討Nobuyuki Kobayashi1），Ryo Aoki2），Kazuya Shimada1），Masato Tamai1），Wataru Yamadera2），Masayuki Iwashita2），Hiroshi Itoh2），Kazuhiko Nakayama2），Kazuhiro Kondo1）

1）Department of Virology, The Jikei University School of Medicine，2）Department of Psychiatry, The Jikei University School of Medicine

Chair Hiroshi Kimura Nagoya University

Gammaherpesvirinae

P2-G-010 マウス γ ヘルペスウイルス感染における IL-27の役割Kyosuke Kanai1），Akiko Watanabe1），Teruhito Yasui2），Osamu Yoshie1）

1）Department of Microbiology, Kinki University Faculty of Medicine，2）Department of Molecular immunology, immunology Frontier Research Center, Osaka University

POSTER DAY 2 （November 23 [MON]）

77

A NEW ERA OF VIRUS RESEARCH

Poster

Day 2

P2-G-011 TM region of CD86 is recognized by inter-transmembrane loop of KSHV MIR2

KSHV 免疫回避分子 MIR2の膜貫通領域間ループは CD86膜貫通領域を認識するMizuho Kajikawa，Koya kato，Minako Kimura，Hideaki Shima，Yoshihiro Inoue，Satoshi IshidoLaboratory of integrative infection immunology, Showa Pharmaceutical University

P2-G-012 Expression of BZLF1 mRNA and ZEBRA protein in EBV-positive cells stimulated with TPA

TPA 刺激による EBV 感染細胞の BZLF1 mRNA および ZEBRA 蛋白発現の検討Ryo Kobayashi，Tomoko Ehara，Tetsuya MatsumotoDepartment of Microbiology, the Tokyo Medical University

P2-G-013 Preparation of infectious recombinant KSHV

KSHV-BAC からの感染性リコンビナントウイルス調製法の検討Tadashi Watanabe，Shota Yagi，Kouhei Hosokawa，Hiroki Kagawa，Masahiro FujimuroDepartment of Cell Biology, Kyoto Pharmaceutical University

P2-G-014 KSHV-encoded K5 induces down-regulation of CD81 via lysosomal pathway.

KSHV がコードする K5はリソソームを介して CD81の分解を誘導する。Kohei Hosokawa，Keisuke Ozawa，Tadashi Watanabe，Hiroki Kagawa，Masahiro FujimuroDepartment of Cell Biology, Kyoto Pharmaceutical University

P2-G-015 IL-2 induced-lytic infection of KSHV

IL-2が誘導する KSHV 溶解感染機構Miho Morifusa1），Chizuka Higashi2），Koji Yamada3），Hiroki Kagawa1），Tadashi Watanabe1），Masahiro Fujimuro1）

1）Department of Cell Biology, Kyoto Pharmaceutical University，2）Molecular cell biology, Sch. of Med., Univ. of Yamanashi，3）Biochemistry, Sch. of Pharm., Hokkaido Univ.

P2-G-016 Elimination of KSHV genome from infected cells using CRISPR-Cas9 system

CRISPR-Cas9による KSHV 潜伏感染細胞からのウイルスゲノム除去Takahiro Yamanaka，Tadashi Watanabe，Hiroki Kagawa，Masahiro Fujimuro京都薬大 薬学部 細胞生物学分野

P2-G-017 Characterization analysis of KSHV ORF34 deletion mutant

KSHV ORF34 遺伝子欠損株の性状解析Mayu Nishimura，Tadashi Watanabe，Hiroki Kagawa，Masahiro FujimuroDepartment of Cell Biology, Kyoto Pharmaceutical University

P2-G-018 Identification of new nuclear localization signal in Epstein-Barr Virus EBNA3C

EB ウイルス EBNA3C の新たな核局在化シグナルGo Matsuda，Ken-ichi ImadomeDivision of Advanced Medicine for Virus Infections, National Research Institute for Child Health and Development

P2-G-019 Dynamics of signaling pathways during HSV-infection and MG132-treatment

単純ヘルぺスウイルス感染と MG132処理による細胞内シグナル伝達の挙動解析Hanako Ishimaru，Tadashi Watanabe，Hiroki Kagawa，Masahiro FujimuroDepartment of Cell Biology Kyoto Pharmaceutical University

P2-G-020 An evaluation of a novel curative medicine S-FMAU, utilizing intractable EBV associated with T/NK lymphoproliferative disorder model mouse.

難治性 EB ウイルス関連 T/NK リンパ増殖性疾患モデルマウスを用いた新規治療医薬S-FMAU の評価研究Fuyuko Kawano1），Eiichi Kodama2），Norio Shimizu3），Go Matsuda1），Shigeyoshi Fujiwara4），Ken-ichi Imadome1）

1）Division of Advanced Medicine for Virus Infections, National Center for Child Health and Development，2）Miyagi Community Health Promotion, the University of Tohoku，3）Center for Stem Cell and Regenerative Medicine, Tokyo Medical and Dental University，4）Department of Allergy and Clinical Immunology

P2-G-021 Identification of cell genes directly regulated by the Epstein-Barr virus nuclear antigen 3CMakoto Ohashi，McChesney Kyle，Johannsen EricDepartment of Medicine, McArdle Laboratory for Cancer Research, University of Wisconsin-Madison

78

THE 63RD ANNUAL MEETING OF THE JAPANESE SOCIETY FOR VIROLOGY

P2-G-022 Comprehensive analysis on immunogenicity of the EBV using LIPS/DDP assay

LIPS/DDP 法を用いた EBV の免疫原性探索Teruhito Yasui1），Takeharu Minamitani1,2），Rika Furuta3），Keisei Kawa3）

1）Department of Molecular Immunology, Research Institute for Microbial Diseases, Osaka University，2）WPI Immunology Frontier Research Center, Osaka University，3）Japanese Red Cross Kinki Block Blood Center

Chairs Yoshio Mori National Institute of Infectious Diseases／Tomohiko Takasaki National Institute of Infectious Diseases

Togaviridae

P2-G-023 Sphingomyelin of host cell plays an important role in the rubella virus infection.Noriyuki Otsuki1），Masafumi Sakata1），Kentaro Hanada2），Kiyoko Okamoto1），Masaki Anraku1），Makoto Takeda1），Yoshio Mori1）

1）Department of Virology 3, National Institute of Infectious Diseases，2）Department of Biochemistry and Cell Biology, National Institute of Infectious Diseases

P2-G-024 Analysis of pseudotyped VSV bearing rubella virus envelope proteins

シュードタイプ VSV を用いた風疹ウイルスの細胞侵入機構の解析Masafumi Sakata1），Hideki Tani2），Kiyoko Okamoto1），Noriyuki Otsuki1），Masaki Anraku1,3），Misato Nagai1），Makoto Takeda1），Yoshio Mori1）

1）Department of Virology III, National Institute of Infectious Diseases，2）Department of Virology I, National Institute of Infectious Diseases，3）Department of Microbiology, Yokohama City University School of Medicine

P2-G-025 Neutralization activity of chikungunya patient sera and disease pathogenicity

チクングニア熱患者の中和活性と病原性Natsuko Kishishita1,2,3），Naokazu Takeda2,3），A-nuegoonpipat Atchareeya4），Sa-ngasang Areerat4），Somchai Sangkitporn4）

1）Laboratory of Adjuvant Innovation, National Institute of Biomedical Innovation, Health and Nutrition，2）Thailand-Japan Research Collaboration Center on Emerging and Reemerging Infections (RCC-ERI)，3）Research Institute for Microbial Diseases, Osaka University，4）National Institute of Health, Department of Medical Sciences, Ministry of Public Health

P2-G-026 Identification of Chemical Compound that Inhibit Chikungunya Virus Replication In Vitro

チクングニアウイルスの増殖を抑制する新規化合物の探索Yuji Wada1），Yasuko Orba1），Michihito Sasaki1），Haruaki Nobori1,2），Akihiko Sato1,2），Hirofumi Sawa1）

1）Research Center for Zoonosis Control, Hokkaido University，2）Discovery Research Laboratory for Core Therapeutic Areas, Shionogi & Co., Ltd.

Flaviviridae Ⅱ

P2-G-027 Pathogenicity of Japanese encephalitis virus isolated from persistently infected cells

日本脳炎ウイルス持続感染細胞産生ウイルスの病原性についてHiroko Toriniwa，Tomoyoshi KomiyaVaccine Research Laboratories, Kitasato Daiichi Sankyo Co,Ltd.

P2-G-028 Dengue outbreak in Myanmar 2013: A decade persistence of predominant dengue virus serotype 1Ngwe Tun Mya Myat1），Kyaw Aung Kyaw1,2,3），Nader Makki1），Rohitha Muthugala1），Takeshi Nabeshima1），Shingo Inoue1），Daitsuke Hayasaka1,2），Myat Thwe Saw3），Thant Kyaw Zin3），Kouichi Morita1,2）

1）Department of Virology, Institute of Tropical Medicine, Nagasaki University，2）Leading Graduate School Program, Nagasaki University，3）Virology Research Division, Department of Medical Research, Myanmar

P2-G-029 Study on development of a portable blood test device in large-scale disaster

大災害時におけるポータブル血液検査装置の開発に関する研究Takenori Shimizu1），Hiroki Ashiba2），Torahiko Tanaka1），Makoto Makishima1），Mutsuo Tanaka3），Makoto Fujimaki2），Koichi Awazu2）

1）Division of Biochemistry Department of Biomedical Sciences Nihon University School of Medicine，2）Electronics and Photonics Research Institute National Institute of Advanced Industrial Science and Technology (AIST)，3）Biomedical Research Institute National Institute of Advanced Industrial Science and Technology (AIST)

79

A NEW ERA OF VIRUS RESEARCH

Poster

Day 2

P2-G-030 A dengue virus serotype 4 dominant outbreak in central Vietnam, 2013Nguyen Thi Thu Thuy1），Yuki Takamatsu2），Dang Thi Dinh1），Nguyen Thi Nam Lien3），Dang Hoai Linh Ly4），Pham Thi Hang4），Bui Thu Thuy2,5,6），Takeshi Nabeshima2），Le Quynh Mai1），Kouichi Morita2），Futoshi Hasebe2,4,7）

1）Department of Virology, National Institute of Hygiene and Epidemiology, Hanoi, Vietnam.，2）Department of Virology, Institute of Tropical Medicine, Nagasaki University, Nagasaki, Japan，3）Department of Microbiology, Hue Central Hospital, Hue, Vietnam，4）Vietnam Research Station, Institute of Tropical Medicine, Nagasaki University, Hanoi, Vietnam，5）Graduate school of biochemical sciences, Nagasaki University，6）Hanoi Preventive Medicine Center, Hanoi, Vietnam，7）Center of International Collaborative Research, Nagasaki University

P2-G-031 Determination of dengue IgG seroprevalence in a dengue endemic adult population: a cross sectional studyMuhammad Azami Nor Azila1,2,3），Moi Meng Ling3），Tomohiko Takasaki3），Salleh Sharifah Azura4），Neoh Hui-min2），Shah Shamsul Azhar2,5），Kamaruddin Mohd Arman2），Abdul Jalal Nazihah2），Ichiro Kurane3），Jamal Rahman2）

1）Graduate School of Comprehensive Human Sciences, University of Tsukuba，2）UKM Medical Molecular Biology Institute, Malaysia，3）Department of Virology 1, National Institute of Infectious Diseases, Japan，4）Department of Medical Virology and Immunology, Universiti Kebangsaaan Malaysia Medical Centre, Malaysia，5）Department of Community Health, Universiti Kebangsaan Malaysia Medical Centre, Malaysia

P2-G-032 Dengue virus infection during an outbreak of chikungunya virus in Democratic Republic of Congo

コンゴ民主共和国で発生したチクングニアウイルス流行中のデングウイルス感染Eiji Ido1），Ahuka Steve2,3），Kentaro Ibuki4），Mihiro Shibata4），Masanori Kameoka5），Muyembe Jean-Jacques2,3）

1）Graduate School of Medical and Dental University, Tokyo Medical and Dental University，2）National Institute of Biomedical Researches, Democratic Republic of Congo，3）University of Kinshasa, Democratic Republic of Congo，4）Kyoto Univeristy，5）Kobe University

P2-G-033 ISAAC 法による日本脳炎ワクチン被接種者末梢血単核球からのヒト抗ウエストナイルウイルス中和モノクローナル抗体の樹立Hideyuki Masaki1），Tatsuhiko Ozawa2），Tomohiko Takasaki3），Ikuko Aoyama4），Takahiro Yumisashi4），Eiji Konishi5），Hiroyuki Kishi2），Atsushi Muraguchi2）

1）Department of Biomedical Engineering, Faculty of Biology-Oriented Science and Technology, Kinki University，2）Department of Immunology, Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama，3）Department of Virology 1, National Institute of Infectious Diseases，4）Department of Infectious Diseases, Osaka Prefectural Institute for Public Health，5）Department of Dengue Vaccine Research, Research Institute for Microbial Diseases, Osaka University

P2-G-034 インドネシア原産天然抽出物および化合物ライブラリを用いた抗デングウイルス活性の評価Norifumi Matake1），Fuad Achmad2），Widyawaruyanti Aty2），Tumewu Lidya2），Permanasari AditaAyu2），Adianti Myrna2），Churrotin Siti2），Ami Matsumoto1），Tomohiro Kotaki1），Masanori Kameoka1）

1）Department of International Health, Kobe University Graduate School of Health Sciences，2）Institute of Tropical Disease, Airlangga University

P2-G-035 Isolation of Drug-resistant Dengue virus in presence of Ribavirin or T-705

Ribavirin 及び T-705存在下における薬剤耐性デングウイルスの分離Haruaki Nobori1,3），Kazuya Yasuo2），Masanori Kobayashi1,3），Ryu Yoshida1），Akihiko Sato1,3），Yasuko Orba3），Hirofumi Sawa3,4）

1）Discovery Research Laboratory for Core Therapeutic Areas, Shionogi & CO.,LTD.，2）Discovery Research Laboratory for Innovative Frontier Medicines, Shionogi & CO.,LTD.，3）Division of Molecular Pathobiology, Research Center for Zoonosis Control, Hokkaido University，4）Global Institution for Collaborative Research and Education, Hokkaido University

P2-G-036 サイクロフェニルのフラビウイルス増殖抑制効果Daiki Tohma1,2），Hirotaka Sato3），Michinori Kakisaka3），Humihiro Kato4），Takayuki Hishiki4），Haruko Takeyama2），Masayuki Saijo1），Tomohiko Takasaki1），Youko Aida3），Shigeru Tajima1）

1）Department of Virology 1, National Institute of Infectious Diseases，2）School of Advanced Science and Engineering, Waseda University，3）Viral Infectious Diseases Unit, RIKEN，4）Laboratory of Primate Model, Experimental Research Center for Infectious Diseases, Institute for Virus Research, Kyoto University

80

THE 63RD ANNUAL MEETING OF THE JAPANESE SOCIETY FOR VIROLOGY

P2-G-037 Mechanisms on anti-dengue virus activity of glucuronide derivatives

グルクロン酸糖誘導体によるデングウイルス感染阻害とそのメカニズムKazuya Hidari1），Tomoko Abe2），Ayumi Sando3），Fumiteru Teraoka4），Tadamune Otsubo4），Kouichi Morita5），Takashi Suzuki2），Hiroaki Tokiwa3），Kiyoshi Ikeda4）

1）Junior College Division, University of Aizu，2）School of Pharmaceutical Sciences, University of Shizuoka，3）Department of Chemistry, Rikkyo University，4）Department of Pharmaceutical Sciences, Hiroshima International University，5）Institute of Tropical Medicine, Nagasaki University

P2-G-038 Anti-JEV effect of deoxyribonucleotide analog EdAP in vitroTakafumi Tasaki1），Yoko Kitagawa1），Hiroshi Ohrui3），Fumio Sugawara2），Souichi Nukuzuma4），Tsutomu Takegami1）

1）Department of Life Science, Medical Research Institute, Kanazawa Medical University，2）Department of Applied Biological Science, Tokyo University of Science，3）Yokohama College of Pharmacy，4）Department of Infectious Diseases, Kobe Institute of Health

P2-G-039 ダニ媒介性脳炎ウイルスのウイルス様粒子を用いた動物種非特異的な新規血清学的診断法の開発Eri Inagaki，Mizuki Sakai，Minato Hirano，Memi Muto，Shintaro Kobayashi，Hiroaki Kariwa，Kentaro YoshiiLaboratory of Public Health, Graduate School of Veterinary Medicine, Hokkaido University

Chairs Kohji Moriishi University of Yamanashi ／ Takaji Wakita National Institute of Infectious Diseases

Hepatitis C virus

P2-G-040 Heterologous vaccination with DNA vaccine and recombinant vaccinia virus carrying the cDNA of HCV induced effective immunity in mouse modelYumiko Shiomaga1），Mitinori Kohara3），Yasuhiro Yasutomi1,2）

1）National Institutes of Biomedical Innovation, Health and Nutrition, Tsukuba Primate Research Center，2）Mie University Graduate School of Medicine, Department of Molecular and Experimental Medicine，3）Tokyo Metropolitan Institute of Medical Science, Viral Infectious Diseases Project

P2-G-041 Human cathelicidin (hCAP18/LL-37) can compensate the role of apolipoproteins in the formation of infectious HCV particlesPuig-Basagoiti Francesc，Takasuke Fukuhara，Chikako Ono，Satomi Yamamoto，Hiroyuki Mori，Takeshi Kurihara，Toru Okamoto，Yoshiharu MatsuuraDepartment of Molecular Virology, Research Institute for Microbial Diseases, Osaka University

P2-G-042 C 型肝炎ウイルスの NS5A 阻害剤スクリーニング系の開発Midori Takeda1,2），Masanori Ikeda2），Shinya Satoh1），Hiromichi Dansako1），Nobuyuki Kato1）

1）Department of Tumor Virology, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences，2）Department of Persistent and Oncogenic Viruses, Kagoshima University Graduate School of Medical and Dental Sciences Center for Chronic Viral Diseases

P2-G-043 A new role for PGA1 in inhibiting hepatitis C virus-IRES-mediated translation by targeting viral translation factorsAtsuko Tsukimoto1），Ryuichi Sugiyama1,4），Hironori Nishistuji2,5），Yuko Shimizu5），Kunitada Shimotohno5），Naoko Miyano-Kurosaki1,2），Yasuyuki Takiguchi1,2），Hiroshi Takaku1,3）

1）Department of Life and Environmental Sciences, Chiba Institute of Technology，2）Graduate School of Engineering,Chiba Institute of Technology，3）Research Institute, Chiba Institute of Technology，4）Department of Molecular Biodefence Research, Yokohama City University Graduate School of Medicine，5）The Research Center for Hepatitis and Immunology, National Center for Global Health and Medicine,

P2-G-044 C 型肝炎ウイルス感染阻害活性を有する Occludin 抗体の樹立と性状解析Yoshimi Shimizu1,2），Yoshitaka Shirasago1），Masuo Kondoh2），Kiyohito Yagi2），Teturo Suzuki3），Takaji Wakita4），Kentaro Hanada1），Masayoshi Fukasawa1）

1）Department of Biochemistry and Cell Biology, National Institute of Infectious Diseases，2）Graduate school of Pharmaceutical Sciences, Osaka University，3）Department of Infectious Diseases, Hamamatsu University School of Medicine，4）Department of Virology II, National Institute for Infectious Diseases

P2-G-045 Inhibition of Host Cellular microRNA Functions by Hepatitis C Virus Infection

C 型肝炎ウイルス感染による宿主マイクロ RNA 機能抑制の分子機構Takahiro Masaki，Takanobu Kato，Takaji WakitaDepartment of Virology II, National Institute of Infectious Diseases

81

A NEW ERA OF VIRUS RESEARCH

Poster

Day 2

P2-G-046 Development of the anti-HCV drug targeting Sgk495, a novel substrate of HCV protease

HCV プロテアーゼにより切断される新規基質タンパク質 Sgk495を標的とした抗 HCV 薬剤の開発Kyosuke Ikeda1），Atsushi Muroi1），Hirotaka Takahashi1），Hiroyuki Takeda1），Tetsuro Suzuki2），Takaji Wakita3），Tatsuya Sawasaki1）

1）Proteo-Science Center, Ehime Univ，2）Department of Infectious Diseases, Hamamatsu University School of Medicine, Japan，3）Department of Virology II, National Institute of Infectious Diseases, Japan

P2-G-047 Genetic and immunological escape in persistent GBV-B infected New World monkeys

慢性 GBV-B 感染における envelope 変異および液性免疫からの逃避Saori Suzuki1），Atsunori Higashino1），Ken-ichi Mori2），Hirotaka Ode3），Kazuhiro Matsuoka3），Yasumasa Iwatani3），Wataru Sugiura3），Yuko Katakai4），Noboru Maki2），Hirofumi Akari1,5）

1）Primate Research Institute, Kyoto University，2）Advanced Life Science Institute，3）Clinical Research Center, National Hospital Organization Nagoya Medical Center，4）Corporation for Production and Research of Laboratory Primates，5）Institute for virus Research, Kyoto University

P2-G-048 コムギ無細胞タンパク質合成系を用いた抗 HCV-E1抗体の作製と評価Takuya Kayamoto1），Hirotaka Takahashi1），Hiroyuki Takeda1），Akira Matumoto2），Masayoshi Hukasawa3），Masakatsu Yamashita2），Tatsuya Sawasaki1）

1）Proteo-Science Center, the University of Ehime，2）愛媛大学　医学系研究科，3）国立感染症研究所　細胞化学部

P2-G-049 Implication of mutations in primate hepacivirus on the spontaneous remission of chronic infection

霊長類へパチウイルス慢性感染後寛解におけるウイルスゲノム変異の意義Atsunori Higashino1），Saori Suzuki1），Hirotaka Ode2），Kazuhiro Matsuoka2），Ken-ichi Mori3），Yuko Katakai4），Sachi Okabayashi4），Noboru Maki2），Yasumasa Iwatani3），Wataru Sugiura3），Hirofumi Akari1）

1）Primate Research Institute, Kyoto University，2）Clinical Research Center, National Hospital Organization Nagoya Medical Center，3）Advanced Life Science Institute，4）Corporation for Production and Research of Laboratory Primates

P2-G-050 Attenuation of MHC class I Expression by Intracellular Accumulation of HCV Core Protein

HCV コアタンパク質細胞内蓄積による MHC class I 発現抑制Takanobu Kato1），Megumi Tasaka-Fujita1,2），Nao Sugiyama1），Takahiro Masaki1），Asako Murayama1），Takaji Wakita1）

1）Department of Virology II, National Institute of Infectious Diseases，2）Department of Gastroenterology and Hepatology, Tokyo Medical and Dental University

P2-G-051 Functional analysis of HCV E1(282-311) region

HCV E1(282-311) 領域の機能解析Noriyuki Watanabe，Tomoko Date，Aly Hussein，Hideki Aizaki，Takaji WakitaDepartment of Virology II, National Institute of Infectious Diseases

P2-G-052 Characterization of the IRES activity in equine hepacivirus 5’UTR

ウマヘパシウイルスが有する IRES 活性の特徴Tomohisa Tanaka，Chen Wenjia，Teruhime Otoguro，Hirotake Kasai，Atsuya Yamashita，Kohji MoriishiDepartment of Microbiology, University of Yamanashi

P2-G-053 Characterization of miR-122-independent propagation of HCV

miR-122非依存的に増殖する HCV 変異株の性状解析Chikako Ono1），Takasuke Fukuhara1），Satomi Yamamoto1），Hiroyuki Mori1），Toru Okamoto1），Hmwe Su Su2），Takaji Wakita2），Kazuhiko Koike3），Yoshiharu Matsuura1）

1）Department of Molecular Virology Research Institute for Microbial Diseases, Osaka University，2）Department of Virology II, National Institute of Infectious Diseases，3）Department of Gastroenterology, Graduate School of Medicine, The University of Tokyo

82

THE 63RD ANNUAL MEETING OF THE JAPANESE SOCIETY FOR VIROLOGY

P2-G-054 Role of NS5A tyrosine phosphorylation in hepatitis C virus particle assembly

C 型肝炎ウイルス粒子形成における NS5A チロシンリン酸化の役割Shota Yamauchi1,3），Kenji Takeuchi1,3），Kazuyasu Chihara1,3），Sun Xuedong1），Chisato Honjoh1,2），Hatsumi Yoshiki1），Hak Hotta4），Kiyonao Sada1,3）

1）Division of Genome Science and Microbiology, Department of Pathological Sciences, Faculty of Medical Sciences, University of Fukui，2）Third Department of Internal Medicine, Faculty of Medical Sciences, University of Fukui，3）Organization for Life Science Advancement Programs, University of Fukui，4）Division of Microbiology, Kobe University Graduate School of Medicine

P2-G-055 Improved ExoQuick protocol for the preparation of exosomes released from human heptoma cellsHiroki Hiramoto1），Hiromichi Dansako1），Youki Ueda1），Shinya Satoh1），Masanori Ikeda2），Nobuyuki Kato1）

1）Department of Tumor Virology, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences，2）Department of Persistent and Oncogenic Viruses, Kagoshima University Graduate School of Medical and Dental Sciences

P2-G-056 Flutamide-mediated Disruption of Lipid Droplets Impairs the Host Permissiveness to Hepatitis C Virus Production

フルタミド誘導性脂肪滴脱制御による C 型肝炎ウイルス粒子産生低下機構の解析Hirofumi Ohashi1,2），Koichi Watashi1,2），Syo Nakajima1,2），Kim Sulyi1），Ryosuke Suzuki1），Hideki Aizaki1），Masayoshi Fukasawa3），Shinji Kamisuki2），Fumio Sugawara2），Naoko Ohtani2），Takaji Wakita1）

1）Department of Virology II, National Institute of Infectious Diseases，2）Tokyo University of Science Graduate School of Science and Technology，3）Department of Biochemistry and Cell Biology, National Institute of Infectious Diseases

P2-G-057 Hepatitis C virus attenuates mitochondrial lipid beta-oxidation by suppressing transcription of mitochondrial trifunctional proteins.Yutaka Amako，Michinori KoharaDepartment of Microbiology and Cell biology, Tokyo Metropolitan Institute of Medical Science

P2-G-058 Inhibitory effect of tyrphostin derivative HD-31 on hepatitis C virus replication via regulation of reactive oxygen species productionRyota Amano，Atsuya Yamashita，Hirotake Kasai，Kohji MoriishiDepartment of Microbiology, Division of Medicine, Graduate School of Interdisplinary Research, University of Yamanashi

Chair Fumihiro Taguchi Nippon Veterinary and Life Science University

Hepeviridae

P2-G-059 Serosurveillance of hepatitis E virus infection among wild animals and hunters

野生動物および狩猟者の E 型肝炎ウイルスの血清調査Kenzo Yonemitsu1），Ryusei Kuwata1），Hiroshi Shimoda1），Masahiko Muto2），Kazuo Suzuki3），Ken Maeda1）

1） Joint Faculty of Veterinary Medicine, Yamaguchi University，2）Faculty of Medicine, Yamaguchi University，3）Hikiiwa Park Center

P2-G-060 Production and characterization of monoclonal antibodies against rat hepatitis E virus capsid protein and their application

ラット HEV カプシドタンパク質に対するモノクローナル抗体の作製とその応用Tominari Kobayashi，Masaharu Takahashi，Tan Ggis，Ji Rintai，Shigeo Nagashima，Tsutomu Nishizawa，Hiroaki OkamotoDivision of Virology, Department of Infection and Immunity, Jichi Medical University School of Medicine

Coronaviridae

P2-G-061 MERS coronavirus infection not found in camels in Japan

日本国内のヒトコブラクダにおける中東呼吸器症候群 (MERS) コロナウイルスの調査Kazuya Shirato1），MERS Surveillance Team2），Miyuki Kawase1），Kazuko Fukushima3），Kensuke Nakajima3），Shutoku Matsuyama1）

1）Department of Virology III, National Institute of Infectious Diseases，2）MERS Surveillance Team，3）Tuberculosis and Infectious Diseases Control Division, Health Service Bureau, Ministry of Health, Labour and Welfare

83

A NEW ERA OF VIRUS RESEARCH

Poster

Day 2

P2-G-062 Inability of rat DPP4 to allow MERS-CoV infection revealed by using a VSV pseudotype bearing truncated MERS-CoV spike proteinShuetsu Fukushi，Aiko Fukuma，Hideki Tani，Satoshi Taniguchi，Masayuki Shimojima，Masayuki SaijoDepartment of Virology I, National Institute of Infectious Diseases

P2-G-063 Human Dipeptidyl Peptidase 4 Transgenic Mice as an Infectious Animal Model for MERS-CoVNaoko Iwata-Yoshikawa1），Tadashi Okamura1,2），Shuetsu Fukushi1），Hanako Sekimukai1,3），Tadaki Suzuki1），Yuko Sato1），Makoto Takeda1），Masato Tashiro1），Hideki Hasegawa1），Noriyo Nagata1）

1）National Institute of Infectious Diseases，2）Research Institute, National Center for Global Health and Medicine，3）Tokyo University of Agriculture and Technology

P2-G-064 Identification of the regions in bovine torovirus N protein involved in the nuclear transport

ウシトロウイルス N 蛋白質の核移行に関する研究Yui Matsunaga，Yukako Kawachi，Fumihiro Taguchi，Makoto Ujike日本獣医生命科学大学　病態獣医学部門　感染症学分野　獣医感染症学教室

P2-G-065 ER α-glucosidase inhibitor compromises the replication of coronaviruses

小胞体 α- グルコシダーゼ阻害薬による抗コロナウイルス機構に関する研究Makoto Ujike1），Yui Matsunaga1），Shiori Arai2），Shutoku Matsuyama3），Wataru Hakamadta2）

1）Nippon Veterinary and Life Science University，2）Nihon University，3）National Institute of Infectious Diseases

P2-G-066 Accurate and rapid whole-genome sequencing of corona virus using Next-generation DNA sequencerSatoshi Murakami1），Osamu Takahashi1），Wataru Hashizume1），Makoto Abe1），Naoki Kamei1），Masato Kondo1），Yuko Tokunaga1），Yoichi Hase1），Miho Muraki1），Ayako Miyazaki2），Seiichi Ohashi2），Tohru Suzuki2）

1）Thermofisher Scientific, Lifetechnologies Japan ltd.，2）Viral Disease and Epidemiology Research Division, National Institute of Animal Health

P2-G-067 Involvement of Lewis X structure in syncytial formation during the later phase of neuropathogenic mouse hepatitis virus infectionMasatoshi Kakizaki，Rihito WatanabeDepartment of Bioinformatics, Faculty of Engineering, Soka University

P2-G-068 A novel serotype of ferret coronavirus in Japan

国内フェレットから発見された新規血清型フェレットコロナウイルスの解析Shohei Minami，Yutaka Terada，Kenzo Yonemitsu，Ryusei Kuwata，Hiroshi Shimoda，Ken MaedaJoint Faculty of Veterinary Medicine, Yamaguchi University

Chair Akira Nishizono Oita University

Rhabdoviridae

P2-G-069 バキュロウイルス発現系を用いた狂犬病ウイルス P タンパク質の精製法の確立Madoka Horiya1,2），Lim Chang-Kweng1），Mutsuyo Ito-Takayama1），Posadas-Herrera Guillermo1），Itoe Iizuka-Shiota1），Yukie Yamaguchi1），Masayuki Saijo1）

1）National Institute of Infectious Diseases，2）Department of Obstetrics and Gynecology , The Jikei University School of Medicine

P2-G-070 Characterization of Recombinant ΔP-RV bearing MERS-CoV S proteinItoe Iizuka-Shiota，Lim Chang-Kweng，Mutsuyo Takayama-Ito，Shuetsu Fukushi，Madoka Horiya，Posadas-Herrera Guillermo，Masayuki SaijoVirology I, National Institution of Infectious Diseases

P2-G-071 Recombinant rabies virus expressing NanoLuc luciferase for antiviral activity assaysAnindita Paulina Duhita1），Michihito Sasaki1），Haruaki Nobori1,2），Akihiko Sato1,2），Naoto Ito3），Makoto Sugiyama3），Yasuko Orba1），Hirofumi Sawa1）

1）Division of Molecular Pathobiology, Research Center for Zoonosis Control, Hokkaido University，2）Discovery Research Laboratory for Core Therapeutic Areas, Shionogi & Co., Ltd.，3）Laboratory of Zoonotic Diseases, Applied Veterinary Medicine, Joint Department of Veterinary Medicine, Faculty of Applied Biological Sciences, Gifu University

84

THE 63RD ANNUAL MEETING OF THE JAPANESE SOCIETY FOR VIROLOGY

P2-G-072 Mechanisms of lactoferrin-mediated enhancement of rabies virus replication in culture

Lactoferrin が狂犬病ウイルスの複製を促進・増強する仕組みAkihiko Kawai1），Tsuneo Uchiyama2）

1）Laboratory of Molecular Microbiology, Research Institute for Production Development，2）Department of Microbiology, Institute of Biomedical Sciences, Tokushima University Graduate School

P2-G-073 街上毒狂犬病ウイルスの細胞内抗原局在と粒子形成部位の検討Minoru Tobiume1），Yuko Sato1），Satoshi Inoue2），Yoshio Suzuki3），Kazumi Shimada3），Tetsuya Uno3），Michiyo Kataoka1）

1）Department of Pathology, National Institute of Infectious Diseases，2）Dept. of Veterinary Science，3）Dept. of Pathology, Asahi general hospital

P2-G-074 Identification of cellular factors involved in aiding CHPV infection, through protein interaction and viral binding studies.Dey Dhritiman1），Ayae Honda2），Chattopadhyay Dhrubajyoti3）

1）Department of Microbiology, University of Calcatta，2）Department of Frontier Bioscience，3）Department of Microbiology/University of Calcatta

P2-G-075 Antiviral mechanism of interferon-tau (IFNT) 1 and C1 in bovine culture cells

ウシインターフェロン・タウ（IFNT）1および C1の牛培養細胞における抗ウイルス作用機構についての解析Yukiko Uno1），Kazuhiko Imakawa2），Sayaka Okada1），Jiro Yasuda1）

1）Department of Emerging Infectious Diseases Institute of Tropical Medicine Nagasaki University，2）Veterinary Theriogenology Veterinary Medical Science the University of Tokyo

Bornaviridae

P2-G-076 Expression and role of the TGF-β family in glial cells infected with Borna disease virus

ボルナ病ウイルスに感染したグリア細胞における TGF-β ファミリーの発現と役割Yoshii Nishino1），Masaru Murakami2），Masayuki Funaba3）

1）Department of Animal Medical Sciences, Faculty of Life Sciences, Kyoto Sangyo University，2）Laboratory of Molecular Biology, Azabu University School of Veterinary Medicine，3）Division of Applied Biosciences, Kyoto University Graduate School of Agriculture

P2-G-077 Analysis of antiviral role and its mechanism of an endogenous bornavirus-like nucleoprotein in Borna disease virus infectionShohei Kojima，Tomoyuki Honda，Keizo TomonagaDepartment of Viral Oncology, Institute for Virus Research, Kyoto University

P2-G-078 Screening of host kinases associated with Borna disease virus infection

ボルナ病ウイルスの感染に関わる宿主キナーゼの探索Tomoya Tokunaga，Tomoyuki Honda，Akiko Makino，Keizo TomonagaDepartment of Viral Oncology, Institute for Virus Research, Kyoto University

P2-G-079 Sequence analysis of a novel parrot bornavirus 5.

新規鳥ボルナウイルス (PaBV-5) の配列解析Ryo Komorizono1），Masayuki Horie2），Tomoyuki Honda1），Akiko Makino1），Keizo Tomonaga1）

1）Department of Viral Oncology, Institute for Virus Research, Kyoto University，2）Transboundary Animal Diseases Research Center, Joint Faculty of Veterinary Medicine, Kagoshima University

P2-G-080 The involvement of IGF2 in the regulation of Borna disease virus production

ボルナ病ウイルス産生への IGF2の関与Akiko Makino，Tomoyuki Honda，Keizo TomonagaInstitute for Virus Research, Kyoto University

85

A NEW ERA OF VIRUS RESEARCH

Poster

Day 2

Chairs Shigeyuki Itamura National Institute of Infectious Diseases ／ Takato Odagiri National Institute of Infectious Diseases

Orthomyxoviridae Ⅱ

P2-G-081 抗ヌクレオカプシド蛋白質抗体のインフルエンザウイルス致死的感染回避における重要性Yoshikazu Fujimoto1），Kinuyo Ozaki1），Gen-Ichiro Uechi2），Hiroki Takakuwa3），Yukiko Tomioka4），Toshiyo Yabuta3），Haruka Suyama1），Sayo Yamamoto1），Masami Morimatsu5），Toshihiro Ito4），Koichi Otsuki3,4），Le Thi Quynh Mai6），Tetsu Yamashiro2），Etsuro Ono1,4）

1）Department of Biomedicine, Graduate School of Medical Sciences, Kyushu University，2）Institute of Tropical Medicine, Nagasaki University，3）Avian Influenza Research Center, Kyoto Sangyo University，4）Avian Zoonosis Research Center, Faculty of Agriculture, Tottori University，5）Department of Disease Control, Graduate School of Veterinary Medicine, Hokkaido University，6）Department of Virology, National Institute of Hygiene and Epidemiology, Vietnam

P2-G-082 Analysis of the immune cells involved in cross-protective immunity against a heterosubtypic influenza A virus strain

インフルエンザウイルス感染における交差感染防御免疫に関与する細胞の解析Hiroshi Ushirogawa，Yasuo Shiohama，Tadasuke Naito，Mineki SaitoDepartment of Microbiology, Kawasaki Medical School

P2-G-083 ラクトパーオキシダーゼシステムにより生成される次亜チオシアン酸イオンの抗インフルエンザウイルス効果Chihiro Sugita1），Kouichirou Shin2），Hiroyuki Wakabayashi2），Hiroki Yoshida1），Wataru Watanabe3），Masahiko Kurokawa1）

1）Department of Biochemistry, Graduate School of Clinical Pharmacy, Kyushu University of Health and Welfare，2）Morinaga Milk Industry Co., Ltd.，3）Department of Microbiology, Graduate School of Clinical Pharmacy, Kyushu University of Health and Welfare

P2-G-084 発酵青バナナ末のインフルエンザウイルス感染予防効果―マウスならびに高齢者を対象とした検証Kenji Horie1,4），Koichi Ogawa2），Eriko Ohgitani4），Yuki Inoue1），Hanako Okano3），Asami Akao3），Takashi Yamada3），Keiko Kurai5），Masataka Itoda5），Osam Mazda4），Toshio Nishikimi5）

1）PHARMA FOODS INTERNATIONAL CO.,LTD，2）Food Care Co.,Ltd，3）Dole Japan, Inc，4）Department of immunology Kyoto Prefectural University of Medicine，5）Wakakusa-Tatsuma Rehabilitation Hospital

P2-G-085 薬剤耐性インフルエンザウイルスの迅速かつ高感度な検出分離法の確立Yuuki Kurebayashi，Tadanobu Takahashi，Takashi SuzukiSchool of Pharmaceutical Sciences, University of Shizuoka

P2-G-086 Analysis of beta-propiolactone sensitive influenza virus

ベータプロピオラクトン感受性インフルエンザウイルスの解析Yutaka Sasaki，Naoto Yoshino，Shigehiro Sato，Yasushi MurakiDepartment of Microbiology, Iwate Medical University

P2-G-087 次世代シークエンサーを用いたバクチオールの抗インフルエンザ活性における遺伝子発現の網羅的解析Masaki Shoji1），Tomoyuki Esumi2），Shuntaro Kohnomi3），Chihiro Yamamoto2），Etsuhisa Takahashi4），Yutaka Suzuki5），Shiro Konishi3），Hiroshi Kido4），Takashi Kuzuhara1）

1）Laboratory of Biochemistry, Faculty of Pharmaceutical Sciences, Tokushima Bunri University，2）Institute of Pharmacognosy attached to Faculty of Pharmaceutical Sciences, Tokushima Bunri University，3）Department of Neurophysiology, Kagawa School of Pharmaceutical Sciences, Tokushima Bunri University，4）Division of Enzyme Chemistry, Institute for Enzyme Research, University of Tokushima，5）Graduate School of Frontier Sciences, University of Tokyo

P2-G-088 Development of monoclonal antibodies specific for H7 HA and their application to rapid detection of influenza A/H7N9 virusHitoshi Takahashi，Mina Nakauchi，Shiho Nagata，Takato Odagiri，Tsutomu KageyamaInfluenza Virus Research Center, National Institute of Infectious Diseases

P2-G-089 季節性細胞培養インフルエンザワクチン製造株開発への取り組み（製造株作製用ウイルスの分離）Yuichi Harada1），Hitoshi Takahashi1），Itsuki Hamamoto1），Hideki Asanuma1），Nami Konomi2），Takato Odagiri1），Eri Nobusawa1）

1）Center for Influenza Virus Research, National Institute of Infectious Diseases，2）Nihon University School of Medicine (Dr. Takahashi’s Office)

86

THE 63RD ANNUAL MEETING OF THE JAPANESE SOCIETY FOR VIROLOGY

P2-G-090 4価インフルエンザ HA ワクチンの一元放射免疫拡散試験における B 型2系統ワクチン株 HA蛋白の交差反応性の解析Noriko Shimasaki，Yuuichi Harada，Shigeyuki Itamura，Takato OdagiriCenter for Influenza Virus Research, National Institute of Infectious Diseases

P2-G-091 ミトコンドリアの形態変化と NLRP3インフラマゾームの活性制御Yuichi Yagita1,2），Takeshi Ichinohe1）

1）Division of Viral Infection, Department of Infectious Disease Control, International Research Center for Infectious Diseases, Institute of Medical Science, The University of Tokyo，2）JSPS Research Fellow

P2-G-092 Efficient generation of human polymeric S-IgA monoclonal antibodies

分泌型多量体 IgA 抗体の作製法の開発Shinji Saito1,4），Tadaki Suzuki1），Akira Ainai1），van Riet Elly2），Yuki Ohara1），Yoshimasa Takahashi3），Shin-ichi Tamura1），Haruko Takeyama4），Hideki Hasegawa1）

1）Department of Pathology, National Institute of Infectious Diseases，2）Influenza Virus Research Center, National Institute of Infectious Diseases，3）Department of Immunology, National Institute of Infectious Diseases，4）Department of Life Science and Medical Bioscience, Waseda University

P2-G-093 Characterization of monoclonal antibodies against H7N9 influenza virus

H7N9インフルエンザウイルスに対するモノクローナル抗体の性状解析Mutsumi Ito1），Ryuta Uraki1），Seiya Yamayoshi1），Kazushi Murakami2），Kazunari Nakaishi3），Satoshi Watabe3），Yoshihiro Kawaoka1,4）

1）Division of Virology, Institute of Medical Science, University of Tokyo，2）BL Co., Ltd.，3）TAUNS LABORATORIES, INC.，4）International Research Center for Infectious Diseases, Institute of Medical Science, University of Tokyo

P2-G-094 Identification of human adaptive mutations in the polymerase complex of H5N1 avian influenza virus in Egypt

H5N1鳥インフルエンザウイルスポリメラーゼ複合体における新規ヒト適応性変異の同定Yasuha Arai1,2,6），Tomo Daidoji2），Madiha Ibrahim3），Kazuo Takahashi4），Yasuo Suzuki5），Takaaki Nakaya2），Tatsuo Sioda1），Kazuyoshi Ikuta6），Yohei Watanabe1,2,6）

1）Department of Viral Infections, Research Institute for Microbial Diseases, Osaka University，2）Department of Infectious Diseases, Graduate School of Medical Science, Kyoto Prefectural University of Medicine，3）Faculty of Veterinary Medicine, Damanhour University, Egypt，4）Department of Laboratory Examination, International University of Health and Welfare，5） Health Scientific Hills, College of Life and Health Sciences, Chubu University，6）Department of Virology, Research Institute for Microbial Diseases, Osaka University

P2-G-095 Isolation of avian H3N6 influenza virus from a poultry duck at a wet market in East Java

鳥 H3N6インフルエンザウイルスの家禽からの分離Adhitya Yoppy1），Yusuke Takahara1,2），Poetranto Djoko1,3），Mareta Aldise1），Poetranto Anna1），Puruhito Edith1），Yoko Shimizu1,2），Wulandari Laksmi1,4），Yudhawati Resti1,4），Setiawati Landia1,4），Setyoningrum Retono1,4），Soegiarto Gatot1,4），Hotta Hak2），Yasuko Mori2），Kazufumi Shimizu1,2）

1）Indonesia-Japan Collaborative Research Center, Institute of Tropical Disease, Airlangga University，2）Center for Infectious Diseases, Kobe University Graduate School of Medicine，3）Faculty of Veterinary Medicine, Airlangga University，4）Dr. Soetomo General Hospital

P2-G-096 Oral administration of L. lactis JCM5805 enhances acquired immune responses against influenza virus antigenHiroaki Suzuki1），Kenta Jounai1,2），Konomi Ohshio1），Toshio Fujii1），Norio Yamamoto3），Daisuke Fujiwara1）

1）Central Laboratories for Key Technologies, Kirin Company, Limited.，2）Technical Development Center, Koiwai Dairy Products Company, Limited.，3）Juntendo University Graduate School of Medicine

P2-G-097 Systematic analysis of antibody repertoire elicited by influenza vaccine by next generation sequencer (NGS)Shigeyuki Itamura1），Naoko Kono1），Sun Lin2），Kazuo Ohnishi2），Hiroyuki Toh3）

1）Center for Influenza Virus Research, National Institute of Infectious diseases，2）Department of Immunology, National Institute of Infectious Disease，3）School of Science and Technology, Kwansei Gakuin University

87

A NEW ERA OF VIRUS RESEARCH

Poster

Day 2

Chair Koki Taniguchi Fujita Health University

Reoviridae

P2-G-098 Genetic diversity of human Rotavirus B detected in BangladeshAung Meiji Soe1），Satoru Aida1），Samsoon Nahar2），Mitsuyo Kawaguchiya1），Noriko Urushibara1），Paul Shyamal2），Hossain Muhammad2），Kobayashi Nobumichi1）

1）Department of Hygiene, Sapporo Medical University School of Medicine，2）Mymensingh Medical College

P2-G-099 バングラデシュにおける G2P[4] ヒトロタウイルス株の全遺伝子配列に基づく分子疫学的解析Satoru Aida1），Souvik Ghosh2），Noriko Urushibara1），Aung Meijisoe1），Paul Shyamal Kumar3），Nobumichi Kobayashi1）

1）Department of Hygiene ,Sapporp Medical University，2）Ross University，3）Mymensingh Medical Callege

P2-G-100 Rotavirus genomic rearrangement impairs packaging efficiency into progeny viruses despite does not confer growth disadvantage to virusesSatoshi Komoto，Tomihiko Ide，Koki TaniguchiDepartment of Virology and Parasitology, Fujita Health University School of Medicine

P2-G-101 Characterization of an unusual human G6P[14] rotavirus strain identified from a child with diarrhea in ThailandTomihiko Ide1），Satoshi Komoto1），Kei Haga2），Kazuhiko Katayama2），Takao Tsuji3），Koki Taniguchi1）

1）Department of Virology and Parasitology, Fujita Health University School of Medicine，2）Department of Virology II, National Institute of Infectious Diseases，3）Department of Microbiology, Fujita Health University School of Medicine

P2-G-102 Molecular epidemiology of rotaviruses based on nearly-full length sequencing across Japan in 2014Yoshiki Fujii1），Doan Yen Hai2），Toyoko Nakagomi2），Osamu Nakagomi2），Kazuhiko Katayama1）

1）Department of Virology 2, National Institute of Infectious Diseases，2）Department of Hygiene and Molecular Epidemiology, Nagasaki University

P2-G-103 Genetic analyses of human group C rotaviruses detected in Japan between 2005 and 2011Doan Yen Hai1），Kei Haga1），Akira Fujimoto1），Yoshiki Fujii1），Reko Takai-Todaka1），Shima Yoshizumi2），Naoki Shigemoto3），Reiko Okamoto4），Koumei Shirabe4），Michiyo Shinohara5），Hiroto Shinomiya6），Kazuhiko Katayama1）

1）Department of Virology II, National Institute of Infectious Diseases, Tokyo, Japan，2）Hokkaido Institute of Public Health, Hokkaido, Japan，3）Hiroshima Prefecture Technology, Hiroshima, Japan，4）Yamaguchi Prefectural Institute of Public Health and Environment, Yamaguchi, Japan，5）Saitama Institute of Public Health, Yoshimi, Saitama, Japan，6）Ehime Institute of Public Health, Ehime, Japan

P2-G-104 Serologic assays for detection of human infection with Pteropine orthoreovirus and evidence of human infection with PRV in VietnamSingh Harpal1），Masayuki Shimojima1），Shuetsu Fukushi1），Hideki Tani1），Tomoki Yoshikawa1），Aiko Fukuma1），Satoshi Taniguchi1），Yang Ming2），Masami Sugamata2），Masayuki Saijo1）

1）Department of Virology 1, National Institute of Infectious Diseases, Tokyo，2）Tokyo Metropolitan University, 1-1, Minami-osawa, Hachioji, Tokyo 192-0372

P2-G-105 Comparison of group A rotavirus VP7 gene in between clinical and sewage water samples after rotavirus vaccine introductionTakafumi Manaka1），Kentaro Tohma1），Shinobu Kazama2），Toshifumi Imagawa1），Yasuko Kayama4），Kazuhisa Kawamura5），Daisuke Nakayama3），Mayuko Saito1），Yoshifumi Masago2），Tatsuo Omura2），Hitoshi Oshitani1）

1）Dpt. of Virology, Tohoku University Graduate School of Medicine，2）New Industry Creation Hatchery Center，3）Nakayama Clinic，4）Kayama Pediatric Clinic，5）Kawamura Pediatric Clinic

88

THE 63RD ANNUAL MEETING OF THE JAPANESE SOCIETY FOR VIROLOGY

Chairs Akifumi Takaori-Kondo Kyoto University ／ Shoji Yamaoka Tokyo Medical and Dental University

Retroviridae, Lentivirus Ⅱ

P2-G-106 Illumina MiSeq を用いた CRF01_AE とサブタイプ B による新たな HIV-1組換え型流行株の解析Satoko Ogawa1,2），Atsuko Hachiya1），Masumi Hosaka1），Masakazu Matsduda1），Hirotaka Ode1），Urara Shigemi1），Reiko Okazaki1），Kenji Sadamasu3），Mami Nagashima3），Takao Toyokawa4），Masao Tateyama5），Yasuhito Tanaka2），Wataru Sugiura1），Yoshiyuki Yokomaku1），Yasumasa Iwatani1,6）

1）Department of Infectious Disease and Immunology, Clinical Research Center, National Hospital Organization Nagoya Medical Center，2）Department of Virology, Nagoya City University，3）Tokyo Metropolitan Institute of Public Health，4）Department of Infectious Diseases, Okinawa Prefectural Southern Medical Center and Children’s Medical Center，5）Department of Infections, Respiratory and Digestive Medicine Control and Prevention of Infectious Diseases, University of the Ryukyu，6）Nagoya University Graduate School of Medicine

P2-G-107 Genetic analysis of Human Immunodeficiency Virus Type 1(HIV-1) in Fukuoka Prefecture

福岡県における HIV-1の遺伝子解析Asako Nakamura1），Mituhiro Hamasaki1），Hideaki Yoshitomi1），Yuki Ashizuka1），Nobuyuki Sera1），Katumi Chijiwa1），Masahiro Takahashi2），Kazuyuki Sagiyama3）

1）Fukuoka Institute of Health and Environmental Sciences，2）Yakuin Takahashi Dermatology Clinic，3）Sagiyama Urology Clinic

P2-G-108 HIV-1陽性献血者検体を用いた生体内 HIV-1変異速度の解析Naoya Shinohara，Rieko Sobata，Chieko Matsumoto，Shigeharu Uchida，Tadashi Nagai，Masahiro Satake1Central Blood Institute, Blood Service Headquarters, Japanese Red Cross Society

P2-G-109 抗 HIV-1活性を有する新規低分子化合物の探索および作用機序の解析Masami Maejima1），Tomomi Wakatsuki-Shiroishi2,3），Daigo Murata2），Nobuhiko Nomura2），Wataru Sugiura1），Yasumasa Iwatani1,3）

1）Department of Infectious Disease and Immunology, Clinical Research Center, National Hospital Organization Nagoya Medical Center，2）TOYAMA CHEMICAL CO., LTD.，3）Nagoya University Graduate School of Menicine

P2-G-110 Novel elite controller model by HIV-1mt-infected cynomolgus macaques

HIV-1mt 感染カニクイザルによる新規エリートコントローラーモデルYohei Seki1），Akatsuki Saito1）， Takeshi Yoshida1,6），Yorifumi Satou2），Shigeyoshi Harada3），Kazuhisa Yoshimura3），Yuji Watanabe1），Yasumasa Iwatani4），Yasuhiro Yasutomi5），Tetsuro Matano3），Tomoyuki Miura6），Hirofumi Akari1,6）

1）Primate Research Institute, Kyoto University，2）Center for AIDS Research, Kumamoto University，3）AIDS Research Center, National Institute of Infectious Diseases，4）Clinical Research Center, National Hospital Organization Nagoya Medical Center，5）Tsukuba Primate Research Center, National Institutes of Biomedical Innovation, Health and Nutrition，6）Institute for Virus Research, Kyoto University

P2-G-111 レンチウイルスベクターを用いたプロテアーゼ薬剤感受性試験Mari Inoue1），Daiki Oyama1），Koushi Hidaka2），Masanori Kameoka1）

1）Department of International Health, Kobe University Graduate School of Health Sciences，2）Faculty of Pharmaceutical Sciences, Kobe Gakuin University

P2-G-112 Population Dynamics Analyses of HIV-1 Mutations within Patients Failing Raltegravir Therapy

Raltegravir 耐性症例における末梢血中 HIV-1ゲノムの変異動態解析Hirotaka Ode1），Masakazu Matsuda1），Atsuko Hachiya1），Yumiko Kito1），Reiko Okazaki1），Urara Shigemi1），Yoshiyuki Yokomaku1），Yasumasa Iwatani1,2）

1）Clinical Research Center, National Hospital Organization Nagoya Medical Center，2）Nagoya University Graduate School of Medicine

P2-G-113 高病原性 SHIV 感染サルのウイルス感染 CD163陽性マクロファージは様々な半減期の集団から構成され，最も半減期の長い集団は ART 下のリザーバーと成り得るYuji Watanabe1,2），Shingo Iwami3），Kanako Matsuura1），Hiromi Mori1），Takayuki Hishiki1），Tomoyuki Miura1），Hirofumi Akari2），Tatsuhiko Igarashi1）

1）Primate model, Institute for Virus Research, Kyoto University，2）Center for Human Evolution Modeling Research, Primate Research Institute, Kyoto University，3）Department of Biology, Faculty of Sciences, Kyushu University

89

A NEW ERA OF VIRUS RESEARCH

Poster

Day 2

P2-G-114 Generation of CCR5 tropic and neutralization-resistant SHIV

CCR5指向性かつ中和抵抗性サル / ヒト免疫不全ウイルスの作製と解析Yuki Ishida，Mai Yoneda，Hiroyuki Otsuki，Takayuki Hishiki，Tatsuhiko Igarashi，Tomoyuki MiuraInstitute for Virus Research, the University of Kyoto

P2-G-115 サル免疫細胞を持つマウスへの SIV 感染実験Yuhei Fujita1），Sho Sekine1），Shun Hashimoto1），Tomoyuki Miura2），Kentaro Ibuki1）

1）Graduate School of Medicine and Faculty of Medicine Kyoto University，2）Institute for Virus Research Kyoto University

P2-G-116 PacBio を用いた HIV 薬剤標的遺伝子領域の多様性解析Haruka Hayashi1,2），Daisuke Motooka2），Emi E. Nakayama3），Dai Watanabe4），Takuma Shirasaka4），Tatsuo Shioda3），Shota Nakamura2），Tetsuya Iida1,2）

1）Department of Bacterial Infections, Research Institute for Microbial Diseases, Osaka University，2）Department of Infection Metagenomics, Research Institute for Microbial Diseases, Osaka University，3）Department of Viral Infections, Research Institute for Microbial Diseases, Osaka University，4）National Hospital Organization, Osaka Medical Center

P2-G-117 Effects of 5HN with high-dose vitamin C on Tscm infected with HIV

５HN と高用量ビタミン C の HIV 感染 Tstm に対する効果Kaku Yu1,2），Rumi Minami1,2），Mariko Komatsu2），Soichiro Takahama1,2），Masahiro Yamamoto1,2）

1）Department of Immunology and Infectious diseases, National Hospital Organization Kyushu Medical Center，2）AIDS/HIV Combined Clinic Center, National Hospital Organization Kyushu Medical Center

P2-G-118 A persistent viral replication model using the OP9-DL1 co-culture system with in vitro HIV-infected CD34+ cells

OP9-DL1と CD34陽性細胞の共培養系を用いた in vitro 胸腺細胞 HIV-1持続感染モデルの樹立Tetsuo Tsukamoto，Seiji OkadaCenter for AIDS Research, Kumamoto University

P2-G-119 Reevaluation of coreceptor usage for the HIV-1 CRF01_AE in ChinaTakaomi Ishida1,2），Gu Lijun1,2），Han Yang3），Yang Feifei2），Zhu Ting3），Song Xiaojing3），Xie Jing3），Jin Gohda1,2），Jun-ichiro Inoue4），Yasushi Kawaguchi5）

1）Research Center for Asian Infectious Diseases, Institute of Medical Science, University of Tokyo, Tokyo, Japan.，2）Japan-China Joint Laboratory of Molecular Immunology & Microbiology, Institute of Microbiology, Chinese Academy of Science, Beijing, PR China.，3）Department of Infectious Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing, PR China.，4）Division of Cellular and Molecular Biology, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.，5）Division of Molecular Virology, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.

P2-G-120 Impact of CTL escape mutations on antigen presentation via MHC class I in a macaque AIDS model

サルエイズモデルにおいて CTL 逃避変異が MHC クラス I 抗原提示へ与える影響の解析Hiroshi Ishii1），Takushi Nomura1），Saori Matsuoka1），Tetsuro Matano1,2）

1）AIDS Research Center, National Institute of Infectious Diseases，2）Institute of Medical Science, University of Tokyo

P2-G-121 Elucidation of action mechanism of BMMP and improvement of its activity by chemical modification

抗 HIV 剤 BMMP の作用機序解明及び活性改良Masahiro Kamo1），Hiroshi Tateishi1），Minami Yamamoto1），Yoshinari Okamoto1），Yuko Morikawa2），Shogo Misumi3），Masami Otsuka1），Mikako Fujita4）

1）Department of Bioorganic Medicinal Chemistry, Faculty of Life Sciences, Kumamoto University，2）Kitasato Institute for Life Sciences and Graduate School for Infection Control, Kitasato University，3）Department of Environmental and Molecular Health Sciences, Faculty of Life Sciences, Kumamoto University，4）Research Institute for Drug Discovery, School of Pharmacy, Kumamoto University

90

THE 63RD ANNUAL MEETING OF THE JAPANESE SOCIETY FOR VIROLOGY

Chairs Masahiro Fujii Niigata University ／ Mari Kannagi Tokyo Medical and Dental University

Retroviridae other than lentivirus

P2-G-122 細胞に発現したエコトロピックマウス白血病ウイルス Env は同種ウイルスの重感染を阻害するNaohiro Watanabe1），Mari Terashi1），Yohei Seki1），Ryuichi Fujisawa2）， Sayaka Takase-Yoden1）

1）Department of Science and Engineering for Sustainable Innovation, Faculty of Science and Engineering, Soka University，2）Medical Science for Nursing, School of Nursing, Dokkyo Medical University

P2-G-123 Prediction of MHC class II epitopes in HTLV-1 proteins: In silico screening of vaccine candidates.Yasuko Sagara1），Masako Iwanaga2），Yasuhiro Sagara3），Yukiko Inoue1），Maiko Morita1），Nobuyo Goto1），Toshiki Watanabe4），Hiroyuki Kiyokawa1）

1）Japanese Red Cross Kyushu Block Blood Center，2）Department of Frontier Life Science, Nagasaki University Graduate School of Biomedical Sciences，3）Faculty of Education, Nakamura Gakuen Univrsity，4）Department of Medical Genome Science, Graduate School of Frontier sciences, The University of Tokyo

P2-G-124 Distribution of bovine leukemia virus in blood and organs of experimentally infected cattle

牛白血病ウイルス実験感染牛におけるウイルスの体内動態Junko Kohara1），Shin-nosuke Takeshima2），Bai Lanlan2），Yuki Matsumoto2），Tsunao Hirai1），Yoko Aida2）

1）Animal Health Group, Animal Research Center, Hokkaido Research Organization，2）Viral Infectious Diseases Unit, RIKEN

P2-G-125 Transformation of rat fibroblast cells by bovine leukemia virus Tax protein

牛白血病ウイルス (BLV)Tax 蛋白質によるラット線維芽細胞の形質転換Hiroshi Mori，Yoshiaki Osawa，Katsunori Okazaki北海道医療大学　薬学部　免疫微生物学

P2-G-126 Inhibition of proliferation and survival of HTLV-1-infected T-cell lines by peridinin

ペリジニンによる HTLV-1感染 T 細胞株の増殖及び生存の阻害Naoki Mori1），Chie Ishikawa1,2），Junichi Tanaka3）

1）Department of Microbiology and Oncology, Graduate School of Medicine, University of the Ryukyus，2）Transdisciplinary Research Organization for Subtropics and Island Studies, University of the Ryukyus，3）Department of Chemistry, Biology and Marine Science, University of the Ryukyu

P2-G-127 HTLV-1感染防止を目指した抗 HTLV-1抗ヒト免疫グロブリン製剤の開発Kiyoko Nojima1），Takuo Mizukami1），Chieko Matsumoto2），Madoka Kuramitsu1），Kenta Tezuka1），Kazunari Yamaguchi1），Kazu Okuma1），Isao Hamaguchi1）

1）Department of Safety Research on Blood and Biological Products, National Institute of Infectious Diseases，2）Central Blood Institute, Japan Red Cross

P2-G-128 牛白血病ウイルス (BLV) 変異型 Tax タンパク質によるヒトがん関連遺伝子の発現調節Yoshiaki Osawa，Kenji Sato，Takashi Tomiyasu，Hiroshi Mori，Katsunori OkazakiDepartment of molecular bioscience, School of Pharmaceuticl Sciences, Health Sciences university of Hokkaido

P2-G-129 No sign of infectious gammaretrovirus production from SNL feeder layer cellsAkira Hashimoto-Gotoh1），Rokusuke Yoshikawa1），Yuki Nakaya1），So Nakagawa2），Takayuki Miyazawa1）

1）Laboratory of Signal Transduction, Department of Cell Biology, Institute for Virus Research, Kyoto University，2）Biomedical Informatics Laboratory, Department of Molecular Life Science, Tokai University School of Medicine

P2-G-130 Novel enhancer region of HTLV-1 provirus

HTLV-1プロウイルスにおける新規エンハンサー領域の解析Misaki Matsuo1,2），Paola Miyazato1,2），Atae Utsunomiya3），Kisato Nosaka4），Yorifumi Satou1,2）

1）International Research Center for Medical Sciences, Kumamoto University，2） Center for AIDS Research, Kumamoto University，3）Department of Hematology, Imamura Bun-in Hospital,Kagoshima,Japan，4）Center for Clinical Sciences, National Center for Global Health and Medicine

P2-G-131 Viral production of G4 gene partial-deleted bovine leukemia virus strains

牛白血病ウイルス G4遺伝子部分欠損株のウイルス産生量Hironobu Murakami，Sae Nikaidou，Reiichiro Sato，Kenji TsukamotoSchool of Veterinary Medicine, Azabu University

91

A NEW ERA OF VIRUS RESEARCH

Poster

Day 2

P2-G-132 日本国内における牛白血病ウイルスの分子疫学Takafumi Tomiyasu，Hiroshi Mori，Yoshiaki Osawa，Katsunori OkazakiFaculty of Pharmaceutical Sciences, Health Sciences University of Hokkaido

P2-G-133 BLV 感染性分子クローンを用いたウイルス産生量とゲノム変異の解析Chihiro Suzuki，Haruna Todaka，Sae Nikaido，Reiichiro Sato，Kenji Tsukamoto，Hironobu MurakamiSchool of Veterinary Medicine, Azabu University

P2-G-134 Activity of the novel dual PI3K/mTOR inhibitor BEZ235 against ATL

新規 PI3K/mTOR 阻害剤 BEZ235の抗 ATL 効果Chie Ishikawa1,2），Naoki Mori2）

1）Transdisciplinary Research Organization for Subtropics and Island Studies, University of the Ryukyus，2）Department of Microbiology and Oncology, Graduate School of Medicine, University of the Ryukyus

P2-G-135 Interaction between cell surface heparan sulfate and ecotropic murine leukemia virus Env protein facilitates infection

細胞表面ヘパラン硫酸とマウス白血病ウイルス Env タンパク質の相互作用は感染を促進するHiroki Saitou1），Yohei Seki1），Yasuhiko Hayashi1），Atsushi Tanaka2），Michiaki Masuda3），Sayaka Takase-Yoden1）

1）Department of Science and Engineering for Sustainable Innovation, Faculty of Science and Engineering, Soka University，2）Research Institute for Microbial Diseases, Osaka University，3）Department of Microbiology, Dokkyo Medical University School of Medicine

P2-G-136 Active vitamin D3 inhibits HTLV-I Tax antigen expression and growth of Tax-positive T cells derived from adult T cell leukemia patients

活性化ビタミン D3は成人 T 細胞白血病患者由来 T 細胞株の HTLV-I の Tax 抗原の発現と増殖を阻害するMarie Kunihiro1,2），Reiko Tanaka1），Takuya Miyagi1），Yoshiaki Takahashi1），Hideki Fujii1），Yuetsu Tanaka1）

1）Department of Immunology, Graduate School of Medicine, University of the Ryukyus，2）EM Research Organization

P2-G-137 The effect of passive immunization of a neutralizing antibody on various routes of HTLV-1 infection using a rat modelYuji Murakami1），Satomi Ando1），Yuetsu Tanaka2），Reiko Tanaka2），Takao Masuda1），Mari Kannagi1），Atsuhiko Hasegawa1）

1）Department of Immunotherapeutics, Tokyo Medical and Dental University，2）Department of Immunology, University of Ryukyus

Chair Michiaki Masuda Dokkyo Medical University

Others

P2-G-138 マイクロ流路チップ－ Direct RT-LAMP 法を用いた呼吸器病原ウイルス遺伝子検出Hideyuki Kubo1），Atsushi Kaida1），Nobuhiro Iritani1），Seiji Yamamoto1,2），Ikuyo Takayama3），Mina Nakauchi3），Hitoshi Takahashi3），Tsutomu Kageyama3）

1）Department of Microbiology, Osaka City Institute of Public Health and Environmental Sciences，2）Virus Division, Osaka Prefectual Institute of Public Health，3）Influenza virus Research Center, National Institute of Infectious Diseases

P2-G-139 紅斑熱非発生地域のマダニより分離したリケッチアの系統樹解析Tsuneo Uchiyama，Hiroshi Yamamoto，Kazuma ShimizuInstitute of Biomedical Sciences, Tokushima University Graduate School

P2-G-140 単純ヘルペスウイルス1型感染マウスにおける γ- アミノ酪酸の細胞性免疫賦活作用についてMinami Shimizu，Miyoka Shimotu，Shinngo Nakamura，Hisahiro Kai，Chiharu Sugita，Hiroki Yoshida，Wataru Watanabe，Masahiko KurokawaDepartment of Biochemistry, Graduate School of Clinical Pharmacy, Kyushu University of Health and Walfare

P2-G-141 Detection of arbovirus from field-collected mosquitoes in Zambia

ザンビア共和国に生息する蚊が保有するウイルスの調査Yasuko Orba1），Hirofumi Sawa1,2）

1）Division of Molecular Pathobiology, Research Center for Zoonosis Control, Hokkaido University，2）Global Station for Zoonosis Control, Global Institution for Collaborative Research and Education (GI-CoRE), Hokkaido University

92

THE 63RD ANNUAL MEETING OF THE JAPANESE SOCIETY FOR VIROLOGY

P2-G-142 ボルナ病ウイルス感染初代神経培養細胞におけるコルチコステロンの影響Naoki Kawakita1），Shinji Owa2），Erika Hujita2），Ryusuke Ono1），Yusaku Miyawaki2），Toshiyuki Saitou1,2），Tomoyuki Honda3），Yoshii Nishino1,2）

1）Division of Life Science, Kyoto Sangyo University，2）Faculty of Life Science, Kyoto Sangyo University，3）Institute for Virus Rsearch, Kyoto University

P2-G-143 異なる経口投与物質で細胞性免疫を賦活化した単純ヘルペスウイルス感染マウス腸内細菌叢の比較Kiyoka Shimotu1），Minami Shimizu1），Shingo Nakamura1），Chihiro Sugita1），Tatuya Matuzaki2），Shiro Takeda2），Hiroki Yoshida1），Shigetoshi Tutumi3），Wataru Watanabe1），Ken Yasukawa4），Masahiko Kurokawa1）

1）Department of Biochemistry, Graduate School of Clinical Pharmacy, Kyushu University of Health and Welfare，2）Minami Nihon Rakuno Kyodo Co., Ltd.，3）Amazonfood Ltd.，4）School of Pharmacy, Nihon University

P2-G-144 Virulence of the Thymidine Kinase-Associated Acyclovir-Resistant Herpes Simplex Virus Type 1

チミジンキナーゼ変異関連 ACV 耐性 HSV-1の病原性Natsumi Omura1,2），Hikaru Fujii1），Tomoki Yoshikawa1），Soichi Yamada1），Shizuko Harada1），Haruko Takeyama2），Masayuki Saijo1）

1）Virology 1, National Institute of Infectious Diseases，2）Department of Life Science and Medical Bioscience, School of Advanced Science and Engineering, Waseda University

P2-G-145 Prevalence and phylogenetic analysis of Orientia tsutsugamushi in small mammals in Hanoi, VietnamKozue Hotta1），Pham T. T. Hang2），Hoang T. Huong2），Ung T.H. Trang2），Kenta Shimizu3），Futoshi Hasebe4），Jiro Arikawa3），Akio Yamada1），Nguyen T. Hoa2），Nguyen L.K. Hang2），Le T.Q. Mai2），Daisuke Hayasaka4）

1）Graduate School of Agricultural and Life Sciences, the University of Tokyo，2）National Institute of Hygiene and Epidemiology, Hanoi, Vietnam，3）Graduate School of Medicine, Hokkiado University, Hokkaido, Japan，4）Institute of Tropical Medicine, Nagasaki University, Nagasaki, Japan

P2-G-146 Ubiquitin-specific protease 14 contributes degradation of cellular prion protein in ubiquitin-proteasome systemDaisuke Ishibashi1），Takujiro Homma1,2），Noriyuki Nishida1）

1）Department of Molecular Microbiology and Immunology, Nagasaki University Graduate School of Biomedical Sciences，2）Department of Biochemistry and Molecular Biology, Graduate School of Medical Science, Yamagata University

P2-G-147 ステンレスワイヤーを用いた新規のプリオン検出法（Wire-QuIC 法）Tsuyoshi Mori，Ryuichiro Atarashi，Katsuya Satoh，Daisuke Ishibashi，Takehiro Nakagaki，Hanae Takatsuki，Takayuki Fuse，Yukiko Miyazaki，Noriyuki NishidaDepartment of Molecular Microbiology and Immunology, Nagasaki University

P2-G-148 Investigation of the porcine circovirus-based episomal vector

豚サーコウイルスゲノムを基盤とするエピゾーマルベクターの検討Tomoya Kobayashi，Kayoko Shiota，Miki Okumura，Yuto Suda，Shin Murakami，Taisuke HorimotoLaboratory of Veterinary Microbiology, Graduate School of Agricultural and Life Sciences, The University of Tokyo

P2-G-149 Comparison of Enteric Virus and Indicator Virus Removal Efficiency in a Full Scale Drinking Water Treatment PlantTorrey Jason1），Tatsuya Asami1），Atsushi Hashimoto2），Hiroyuki Katayama1），Hiroaki Furumai1）

1）School of Engineering, The University of Tokyo，2）Faculty of Life and Environment, Prefectural University of Hiroshima